Paul, Sanjoy Ketan
Roberts, Jason A.
Lipman, Jeffrey
Deans, Renae
Samanta, Mayukh
Funding for this research was provided by:
National Health and Medical Research Council
Article History
First Online: 10 August 2018
Compliance with Ethical Standards
:
: Sanjoy Ketan Paul has acted as a consultant and/or speaker for Novartis, GI Dynamics, Roche, AstraZeneca, Guangzhou Zhongyi Pharmaceutical and Amylin Pharmaceuticals LLC, and has received GRANTs in support of investigator and investigator-initiated clinical studies from Merck, Novo Nordisk, AstraZeneca, Hospira, Amylin Pharmaceuticals, Sanofi-Aventis and Pfizer. Jeffrey Lipman declares an unrelated consultancy for MSD. Jason A. Roberts declares unrelated consultancies for bioMerieux, MSD, Astellas, Accelerate Diagnostics, Bayer and Infectopharm over the last 3 years, as well as investigator-initiated Grants from MSD and Cardeas Pharma. Mayukh Samanta and Renae Deans have no conflicts of interest to declare.